#Israel #Rehovot #Amai Proteins #sweelin® #Reduced Sugar

Amai Proteins' Sweelin® Gains Approval in Israel

Amai Proteins, an innovative biotechnology company, has recently achieved a significant milestone by securing official approval for its flagship product, Sweelin®, from the Israeli Ministry of Health. This development represents a pivotal moment for the food and beverage industry, opening doors to a new generation of reduced-sugar products in Israel and enhancing healthier eating options for consumers.

Regulatory Breakthrough

The approval granted to Sweelin® comes as a part of a broader trend wherein several countries have recognized this sweet protein as a safe and viable alternative to traditional sweeteners. Following similar authorizations in the United States and Singapore, Israel has now become the third market to embrace this novel ingredient in less than six months, reflecting a growing global acceptance of the product.

Sweelin® has demonstrated its capacity for versatility, being cleared for use across more than 25 categories of food and beverages. Its formulation allows food manufacturers to significantly reduce sugar content—up to 70%—without compromising on taste, a key element in food product development.

The Benefits of Sweelin®

Amai Proteins has positioned Sweelin® as an essential tool for manufacturers who are keen on addressing the increasing consumer demand for healthier, clean-label options. Here are some notable benefits of Sweelin®:

• - High Sweetness Potency: Sweelin® is estimated to be 3,000 times sweeter than sugar, which means that only a fraction of the product is required to achieve desired sweetness levels.
• - Clean Taste: The product is designed to offer an excellent taste profile, free of any artificial aftertaste often associated with other sweeteners.
• - Health-Friendly: With published clinical evidence showing no impact on blood glucose, insulin, or GLP-1 levels, Sweelin® stands apart as a truly health-friendly sweetening option.
• - Manufacturing Compatibility: Being protein-based and produced through precision fermentation, Sweelin® integrates seamlessly into various industrial food-processing applications, making it a practical option for food manufacturers.

A Vision for Healthier Products

Dr. Amir Guttman, CEO of Amai Proteins, emphasized the importance of this approval, noting, "Receiving regulatory approval in Israel is an important commercial milestone for Amai Proteins. We are especially proud that Sweelin® is the first sweet protein approved in Israel." His enthusiasm is echoed by the potential benefits to local food manufacturers who can leverage this innovative ingredient to create products that align with health-conscious trends without sacrificing flavor.

This approval aligns with Amai Proteins’ broader strategy of enhancing food innovation while being attuned to regulatory environments, focusing on safety and efficacy.

Future Implications

The momentum garnered from these regulatory approvals has led Amai Proteins to actively collaborate with various food and beverage manufacturers to facilitate the commercialization of drinks, snacks, and meals featuring Sweelin®. The dedication to fostering healthier eating habits while minimizing sugar intake may well position Sweelin® as a game-changer in the arena of functional food ingredients.

Looking ahead, the integration of Sweelin® into the Israeli market is expected to encourage more companies to explore alternatives that contribute to a healthier future. Amai Proteins aims to scale its operations internationally, ensuring that consumers worldwide can benefit from reduced-sugar options that don't compromise taste.

For more information about Sweelin® and its applications, visit Amai Proteins.